European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - VSC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - VSC

  • Market Cap€70.290m
  • SymbolXETRA:VSC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINDE000A14KL72

Company Profile

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. The company's pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: Resminostat and Domatinostat.4SC AG focuses on the development of novel small molecule drugs that can target key indications in cancer through epigenetic mechanisms. The company’s product consists of resminostat, 4SC-202, and 4SC-208.

Latest VSC news

Currently there for this company. Visit our news hub for other news .